首页> 外文期刊>Journal of Surgical Research: Clinical and Laboratory Investigation >Role of non-MLC20 phosphorylation pathway in the regulation of vascular reactivity during shock
【24h】

Role of non-MLC20 phosphorylation pathway in the regulation of vascular reactivity during shock

机译:非MLC20磷酸化途径在休克期间调节血管反应性中的作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Studies have shown that shock-induced vascular hyporeactivity is associated with the decrease in 20-kDa myosin light chain (MLC20) phosphorylation. Whether and how a non-MLC20 phosphorylation pathway participates in the regulation of vascular reactivity after shock is not known. Methods With superior mesentery artery (SMA) obtained from rats in hemorrhagic shock and hypoxia-treated SMA, the regulatory effect of platelet-derived growth factor (PDGF) on vascular reactivity and the roles of caldesmon, 27-kDa heat shock protein (HSP27), extracellular signal-regulated protein kinase (Erk), and p38 mitogen-activated protein kinase (MAPK), the main molecules that are involved in the non-MLC20 phosphorylation pathway of the regulation of smooth-muscle contraction, were investigated. Results PDGF (40-100 ng/mL) increased the vascular reactivity after shock in a dose-dependent manner, whereas it did not increase the MLC20 phosphorylation in a dose-dependent manner. PDGF with concentration more than 60 ng/mL did not further increase the MLC20 phosphorylation, whereas upregulated the phosphorylation of HSP27, Erk, and p38MAPK, and the activity of myosin adenosine triphosphatase in SMAs, and downregulated the phosphorylation of caldesmon. p38MAPK antagonist, SB203580, not only antagonized PDGF-induced increase in the phosphorylation of HSP27, but also antagonized PDGF-induced decrease in the phosphorylation of caldesmon, whereas Erk antagonist, PD98059, only antagonized PDGF-induced decrease in the phosphorylation of caldesmon. Conclusions These findings suggested that a non-MLC20 phosphorylation pathway participated in the regulation of vascular reactivity after shock. Caldesmon- and HSP27-mediated change in myosin adenosine triphosphatase activity and Erk and p38MAPK played an important role in this process. These findings may provide some potential targets for the treatment of vascular hyporeactivity after shock.
机译:背景研究表明,休克引起的血管反应性低下与20 kDa肌球蛋白轻链(MLC20)磷酸化的减少有关。未知非MLC20磷酸化途径是否以及如何参与休克后血管反应性的调节。方法采用大鼠失血性休克并经缺氧处理的SMA制成的肠系膜上动脉(SMA),血小板源性生长因子(PDGF)对血管反应性的调节作用以及Caldesmon,27 kDa热休克蛋白(HSP27)的作用,细胞外信号调节蛋白激酶(Erk)和p38丝裂原活化蛋白激酶(MAPK),这是参与调节平滑肌收缩的非MLC20磷酸化途径的主要分子。结果PDGF(40-100 ng / mL)以剂量依赖的方式增加了休克后的血管反应性,而没有以剂量依赖的方式增加MLC20的磷酸化。浓度超过60 ng / mL的PDGF不会进一步增加MLC20的磷酸化,而上调HSP27,Erk和p38MAPK的磷酸化,并抑制SMA中肌球蛋白腺苷三磷酸酶的活性,并下调caldesmon的磷酸化。 p38MAPK拮抗剂SB203580不仅拮抗PDGF诱导的HSP27磷酸化增加,还拮抗PDGF诱导的Caldesmon磷酸化减少,而Erk拮抗剂PD98059仅拮抗PDGF诱导的Caldesmon磷酸化减少。结论这些发现表明,非MLC20磷酸化途径参与了休克后血管反应性的调节。 Caldesmon和HSP27介导的肌球蛋白腺苷三磷酸酶活性的改变以及Erk和p38MAPK在此过程中起重要作用。这些发现可能为休克后血管反应性低下的治疗提供一些潜在的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号